<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For the last decade we have observed and regularly followed 49 patients with the ocular type of <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty-six patients were males and 13 were females </plain></SENT>
<SENT sid="2" pm="."><plain>Regardless of whether the initial ocular presenting symptoms were in the anterior or posterior segment, both segments were involved within two years </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0001924'>Sterile</z:mp> <z:e sem="disease" ids="C0020641" disease_type="Disease or Syndrome" abbrv="">hypopyon</z:e> was recorded in 17 out of the 49 patients during the process of follow-up </plain></SENT>
<SENT sid="4" pm="."><plain>In three of the patients <z:e sem="disease" ids="C0020641" disease_type="Disease or Syndrome" abbrv="">hypopyon</z:e> was the presenting symptom </plain></SENT>
<SENT sid="5" pm="."><plain>Characteristically there was a lack of corneal or scleral involvement in the disease process </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients responded initially to treatment with steroids, but 42 had a course of treatment with cytotoxic-immunosuppressive drugs for various lengths of time after 'resistance' to steroids developed </plain></SENT>
<SENT sid="7" pm="."><plain>Although definitely effective in reducing the intensity of the ocular inflammatory processes, it is not clear yet whether these modes of treatment have any dramatic effect of the visual prognosis of the affected eyes </plain></SENT>
<SENT sid="8" pm="."><plain>Despite intensive follow-up and treatment, loss of useful visual acuity has occurred in 74% of the eyes six to 10 years after the start of the ocular symptoms </plain></SENT>
</text></document>